Allison Hagerman
Chief Technology Officer · ONCOLYTICS BIOTECH INC
- 2026
- Jun 3, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Allison Hagerman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Bernd R. Seizinger - $187K in ONCY purchases and sales in the last 12 months
- Jared Kelly - $34K in ONCY purchases and sales in the last 12 months
- Patricia S. Andrews - $30K in ONCY purchases and sales in the last 12 months
- Andrew Aromando - $25K in ONCY purchases and sales in the last 12 months
- Wayne Pisano - $25K in ONCY purchases and sales in the last 12 months
- Deborah Margaret Brown - $21K in ONCY purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Allison Hagerman?
Allison Hagerman is a corporate insider, tracked as Chief Technology Officer of ONCOLYTICS BIOTECH INC (ONCY). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Allison Hagerman last file a Form 4?
The most recent primary Form 4 on record is dated 3 June 2026, one of 2 filings going back to 2026.
Has Allison Hagerman been buying or selling stock?
Recorded transactions: 1 open-market purchase ($8K) and 0 open-market sales across all tracked filings.
